DHR Awarded Pediatric Asthma Certification  from the Joint Commission

Translate to Spanish or other 102 languages!

Pediatric Asthma

- Advertisement -

Mega Doctor News – 

Edinburg, TX––Doctors Hospital at Renaissance (DHR) today announced that it has earned The Joint Commission’s Gold Seal of Approval® for Pediatric Asthma Certification. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.

To receive this award, DHR underwent a rigorous on-site review in April 2016. Joint Commission experts evaluated compliance with national disease-specific care standards as well as with pediatric asthma-specific requirements. Clinical practice guidelines and performance measures also were assessed.

- Advertisement -

The Pediatric Asthma program at DHR was developed to engage with the community and increase public awareness about asthma management. The team of pediatric asthma specialists at DHR is dedicated to ensuring that each child can live an active and healthy lifestyle. The interdisciplinary team at DHR includes physicians, physician assistants, nurse practitioners, case managers/social workers, pharmacists, dieticians, respiratory therapists, nurses, asthma coordinators, behavioral health care providers and laboratory personnel.

Established in 2002 and awarded for a two-year period, The Joint Commission’s Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas:

•Compliance with consensus-based national standards;

•Effective use of evidence-based clinical practice guidelines to manage and optimize care; and

- Advertisement -

•An organized approach to performance measurement and improvement activities.

“Doctors Hospital at Renaissance has thoroughly demonstrated a high level of care for pediatric patients with asthma,” said Wendi J. Roberts, RN, executive director, Certification Programs, The Joint Commission. “We commend DHR for becoming a leader in pediatric asthma care, potentially providing a higher standard of service for young asthmatic patients in its community.”

“DHR is pleased to receive Disease-Specific Care Certification from The Joint Commission, the premier health care quality improvement and accrediting body in the nation,” added Israel Rocha, DHR’s Chief Executive Officer. “The certification provides us with the framework to create a culture of excellence for those in our community.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -